“migraine” Archives

Entry Author Date Location
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
In Race to Relief, Amgen Touts New But Incomplete Migraine Data 06/09/16 San Francisco
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Arteaus, With $18M From Atlas and OrbiMed, Forges Ahead on Migraine-Prevention Drug 10/19/11 Boston
Zogenix Strategy Unfolds as it Unveils Plans for Next Drug-and-Device Combo 07/19/11 San Diego
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News 03/03/11 Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
Saagara Planning New Health Apps, Getting Advice from Ted Dacko, Former HealthMedia Chief 12/14/10 Detroit Ann Arbor
Stopping Migraines Before They Hurt: NeurAxon Pursues New Pain Drug 02/02/09 Boston
Torrey Pines Therapeutics Permitted to Begin Phase III Trial of Migraine Drug 10/01/08 San Diego
Page 1 of 1